Tofacitinib for Acute Severe Colitis: When the going Gets Tough, the Tough Get Going

被引:5
作者
D'Amico, Ferdinando [1 ,2 ,3 ]
Peyrin-Biroulet, Laurent [2 ,3 ]
Danese, Silvio [1 ,4 ]
机构
[1] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini, I-20090 Milan, Italy
[2] Univ Lorraine, Dept Gastroenterol, Vandoeuvre Les Nancy, France
[3] Univ Lorraine, Univ Hosp Nancy, INSERM, NGERE,U1256, Vandoeuvre Les Nancy, France
[4] Humanitas Clin & Res Ctr, Dept Gastroenterol, Milan, Italy
关键词
SEVERE ULCERATIVE-COLITIS; RESCUE THERAPY; HERPES-ZOSTER; RISK;
D O I
10.1093/ecco-jcc/jjaa028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:883 / 885
页数:3
相关论文
共 18 条
[1]   Efficacy of Induction Therapy With High-Intensity Tofacitinib in 4 Patients With Acute Severe Ulcerative Colitis [J].
Berinstein, Jeffrey A. ;
Steiner, Calen A. ;
Regal, Randolph E. ;
Allen, John, I ;
Kinnucan, Jami A. R. ;
Stidham, Ryan W. ;
Waljee, Akbar K. ;
Bishu, Shrinivas ;
Aldrich, Leslie B. ;
Higgins, Peter D. R. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) :988-+
[2]   Risk for Herpes Zoster in Tofacitinib-Treated Rheumatoid Arthritis Patients With and Without Concomitant Methotrexate and Glucocorticoids [J].
Curtis, Jeffrey R. ;
Xie, Fenglong ;
Yang, Shuo ;
Bernatsky, Sasha ;
Chen, Lang ;
Yun, Huifeng ;
Winthrop, Kevin .
ARTHRITIS CARE & RESEARCH, 2019, 71 (09) :1249-1254
[3]  
Czarska-thorley D, NTR
[4]   Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience [J].
D'Amico, Ferdinando ;
Parigi, Tommaso Lorenzo ;
Fiorino, Gionata ;
Peyrin-Biroulet, Laurent ;
Danese, Silvio .
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
[5]  
FDA, NTR
[6]   Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis [J].
Hanauer, Stephen ;
Panaccione, Remo ;
Danese, Silvio ;
Cheifetz, Adam ;
Reinisch, Walter ;
Higgins, Peter D. R. ;
Woodworth, Deborah A. ;
Zhang, Haiying ;
Friedman, Gary S. ;
Lawendy, Nervin ;
Quirk, Daniel ;
Nduaka, Chudy I. ;
Su, Chinyu .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) :139-147
[7]   Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management (Publication with Expression of Concern) [J].
Harbord, Marcus ;
Eliakim, Rami ;
Bettenworth, Dominik ;
Karmiris, Konstantinos ;
Katsanos, Konstantinos ;
Kopylov, Uri ;
Kucharzik, Torsten ;
Molnar, Tamas ;
Raine, Tim ;
Sebastian, Shaji ;
de Sousa, Helena Tavares ;
Dignass, Axel ;
Carbonnel, Franck .
JOURNAL OF CROHNS & COLITIS, 2017, 11 (07) :769-784
[8]   Tofacitinib for Rescue Therapy in Acute Severe Ulcerative Colitis: A Real-world Experience [J].
Kotwani, Prashant ;
Terdiman, Jonathan ;
Lewin, Sara .
JOURNAL OF CROHNS & COLITIS, 2020, 14 (07) :1026-1028
[9]   Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation [J].
Lohan, Christoph ;
Diamantopoulos, Alex ;
LeReun, Corinne ;
Wright, Emily ;
Bohm, Natalie ;
Sawyer, Laura Marie .
BMJ OPEN GASTROENTEROLOGY, 2019, 6 (01)
[10]   Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids [J].
Narula, Neeraj ;
Marshall, John K. ;
Colombel, Jean-Frederic ;
Leontiadis, Grigorios I. ;
Williams, John G. ;
Muqtadir, Zack ;
Reinisch, Walter .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (04) :477-+